Henry Schein EPS HSIC
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 27, 2026
- $3.43
- Latest quarter, Q2 FY26
- $0.82
- +17% on a year earlier
- Fiscal year 2025
- $3.27
- +7% on the year before
Henry Schein's earnings per share was $3.43 over the twelve months to Jun 27, 2026, up 10% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.82, up 17% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 3% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $3.27 | +7% |
| FY2024 | $3.05 | −3% |
| FY2023 | $3.16 | −19% |
| FY2022 | $3.90 | −13% |
| FY2021 | $4.46 | +59% |
| FY2020 | $2.81 | −40% |
| FY2019 | $4.69 | +34% |
| FY2018 | $3.49 | +37% |
| FY2017 | $2.55 | −18% |
| FY2016 | $3.10 | +9% |
| FY2015 | $2.85 | +5% |
| FY2014 | $2.71 | +10% |
| FY2013 | $2.46 | +14% |
| FY2012 | $2.15 | +9% |
| FY2011 | $1.99 | +13% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.82 | +17% | $3.43 | |
| Q1 FY26 | $0.92 | +5% | $3.31 | |
| Q4 FY25 | $0.85 | +13% | $3.27 | |
| Q3 FY25 | $0.84 | +8% | $3.17 | |
| Q2 FY25 | $0.70 | −13% | $3.11 | |
| Q1 FY25 | $0.88 | +22% | $3.21 | |
| Q4 FY24 | $0.75 | +436% | $3.05 | |
| Q3 FY24 | $0.78 | −26% | $2.44 | |
| Q2 FY24 | $0.80 | −25% | $2.71 | |
| Q1 FY24 | $0.72 | −21% | $2.97 | |
| Q4 FY23 | $0.14 | −60% | $3.16 | |
| Q3 FY23 | $1.05 | −4% | $3.37 |
Against its peers
Companies in Medical - Distribution nearest Henry Schein's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HSICHenry Schein | $3.43 | +10% a year |
| CAHCardinal Health | $7.24 | +12% a year |
| CORCencora | $13.46 | +38% a year |
| HLFHerbalife | $1.55 | −51% a year |
| Peer median | $7.24 |
Where Henry Schein ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Henry Schein
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.